STEPHANIE H. PINCUS, M.D., M.B.A.

269 Middlesex Road Buffalo Veterans Administration Hospital

Buffalo, New York 14216 3495 Bailey Avenue
Phone: (716) 873-1296 Buffalo, New York 14215
Cell (716) 570-5986 Phone: (716) 862-8523
Fax: (716) 874-3275 Fax: (716) 862-8533
E-mail: shp@shpincus.com E-mail: stephanie.pincus@va.gov

EDUCATION

M.B.A., J.L. Kellogg Graduate School of Management, Northwestern University, Evanston, IL, 1998
M.D., cum laude, Harvard Medical School, Boston, MA, 1968
B.A., Reed College, Portland, OR, 1964

POSTGRADUATE TRAINING

Visiting Scientist, Biogen Research Corporation, Cambridge, MA, 1987-88

Research Fellow in Dermatology, Harvard Medical School, Children’s Hospital Medical Center,
Boston, MA, 1974-75
Assistant in Medicine, Senior Fellow (Resident) Division of Dermatology, Dept. of Medicine,
University of Washington, Seattle, WA, 1972-74
Resident, Dept. of Medicine, University of Washington Affiliated Hospitals, Seattle, WA, 1971-72
Fellow, Research Training Unit, Dept. of Medicine, University of Washington, Seattle, WA, 1969-71
Intern, Boston City Hospital, Boston, MA, 1968-69

BOARD CERTIFICATION

Diplomate, American Board of Dermatology, 1975

Diplomate, American Board of Internal Medicine, 1973
Diplomate, National Board of Medical Examiners, 1969

LICENSURE

State of New York, 1989

State of California, 1969
 Stephanie H. Pincus, M.D., M.B.A.

HOSPITAL APPOINTMENTS

Designated Education Officer, Veterans Administration Hospital, Buffalo, NY, 2009-

Chief of Dermatology, Veterans Administration Hospital, Buffalo, NY, 2000-00
Clinical Director of Dermatology, Kaleida Health, Buffalo, NY, 1998-00
Chief of Dermatology, Veterans Administration Hospital, Buffalo, NY, 1995-97
Chief, Department of Dermatology, Children’s Hospital of Buffalo, Buffalo, NY, 1991-98
Chief, Department of Dermatology, Buffalo General Hospital, Buffalo, NY, 1989-98
Associate Dermatologist-in-Chief, New England Medical Center, Boston, MA, 1986-89
Director, Phototherapy Unit, Dept. of Dermatology, New England Medical Center, Boston, MA,
1985-87
Physician, Dept. of Medicine, New England Medical Center, Boston, MA, 1982-89
Dermatologist, Dept. of Dermatology, New England Medical Center, Boston, MA, 1982-89
Assistant Physician, Dept. of Medicine, New England Medical Center, Boston, MA, 1977-82
Chief, Dermatology Section, Dept. of Medicine, Veterans Administration Hospital,
Seattle, WA, 1975-77
Assistant in Medicine, Beth Israel Hospital, Boston, MA, 1974-75
Fellow, Dept. of Medicine (Dermatology), Children’s Hospital Medical Center, Boston, MA, 1974-75

FACULTY APPOINTMENTS

Professor and Chair Emeritus, Department of Dermatology, University at Buffalo, Buffalo, NY,
2001-
Professor, Department of Medicine, University at Buffalo, Buffalo, NY, 1989-00
Professor and Chair, Department of Dermatology, School of Medicine and Biological Sciences,
University at Buffalo, Buffalo, NY, 1989-00
Vice-Chairman, Dept. of Dermatology, Tufts University School of Medicine, Boston, MA, 1982-89
Associate Professor, Dept. of Medicine, Tufts University School of Medicine, Boston, MA, 1982-89
Associate Professor, Dept. of Dermatology, Tufts University School of Medicine, Boston, MA, 1982-
89
Assistant Professor, Dept. of Dermatology, Tufts University School of Medicine, Boston, MA, 1979-
82
Lecturer, Dept. of Medicine, Boston University School of Medicine, Boston, MA, 1977-89
Member, Dept. of Immunology, Tufts University School of Medicine, Boston, MA, 1977-89
Assistant Professor, Dept. of Medicine, Tufts University School of Medicine, Boston, MA, 1977-82
Assistant Professor, Dept. of Medicine, University of Washington, Seattle, WA, 1975-77

AWARDS AND HONORS

The World Who’s Who of Women, 1996

Herman Gardner Memorial Lecturer, Baylor College of Medicine, 1995
Eduard G. Friedrich Memorial Lecturer, University of Florida, 1994
Best Doctors in America, 1993-
Clinical Investigator Award, National Institutes of Health, 1978-81
Research Associate, Veterans Administration, 1975-77
Dermatology Foundation Fellowship, 1974-75, 1977-78
Alpha Omega Alpha, Harvard Medical School, 1968
Phi Beta Kappa, Reed College, 1964

2
 Stephanie H. Pincus, M.D., M.B.A.

ACADEMIC APPOINTMENTS AND PROFESSIONAL WORK EXPERIENCE

Designated Education Officer, Buffalo Veterans Administration Hospital (VAWNY

Healthcare System), Buffalo, NY, 2009-present
Key Responsibilities:
• Provide leadership and oversee graduate medical education (GME)
• Manage relationships with the University at Buffalo and other academic partners in Buffalo
• Develop programs and policies to assure compliance with national standards
Key Accomplishments:
• Created organizational structures to coordinate GME with improved management and
administrative oversight
• Implemented new processes to improve documentation, compliance, and monitoring, achieving
national expectations
• Enhanced recognition of Buffalo GME on both a local and national level, increasing numbers of
funded GME positions by more than 10% through competitive RFPs

Founding Director, The RAISE Project, Society for Women’s Health Research,
Washington, DC, 2005–present
Key Responsibilities:
• Provide leadership to innovative national program
• Establish national program to enhance recognition of women’s achievements in science,
technology, engineering, mathematics and medicine
• Represent project to national foundations, professional organizations, and educational institutions
• Set policy and procedures to sustain project goals
• Secure funding to provide fiscal stability
• Dialogue with national leaders in women’s career development to promote recognition of The
RAISE Project
• Oversee development of website and communication activities
• Assure efficient fiscal management of resources
Key Accomplishments:
• Secured start-up funding from the Alfred P. Sloan Foundation
• Launched dynamic website currently cataloguing and displaying over 500 awards
• Analyzed award data to substantiate discrepancy between awards received by men and women
• Presented findings and activities to national organizations including the AAMC
• Created national presence of The RAISE Project through public recognition and media discussion
• Initiated national discussion of importance of equity in scientific awards
• Partnered with Association for Women in Science to promote a Culture of Celebration and
Recognition
• Established a National Advisory Board with a broad based coalition of support from leaders in
science, technology, engineering, and medicine
• Recognized in national press including Science Magazine and The Scientist

Chief Academic Affiliations Officer, Office of Academic Affiliations, Veterans Health

Administration, Department of Veterans Affairs, 2000–2004
Key Responsibilities:
3
 Stephanie H. Pincus, M.D., M.B.A.

• Led health professions education mission of VA (The VA is the nation’s largest provider of
health professional education, with over 76,000 trainees, including almost 28,000 medical
residents, 16,000 medical students, and 32,000 associated health students who participate in
clinical training every year)
• Oversaw operation of VHA’s educational activities, including its affiliations with 107 medical
schools, and approximately 1500 affiliations with other academic schools and programs
• Developed and implemented policy regarding all aspects of the health professions education
programs with VHA’s 163 facilities
• Managed efficient resource allocation of the more than $450M educational budget in support of
VA’s health professional education mission
• Allocated salary support for almost 9,000 paid medical resident positions and 3500 paid positions
in associated health including nursing, podiatry, optometry, psychology, and audiology
• Advised Deputy Under Secretary for Health and the Under Secretary for Health on matters
related to education of future health care professions
• Managed relationship between VA and its academic partners through communication with
affiliates and the Association of American Medical Colleges
• Represented VA at national organizations concerned with education of health professionals,
(including the federally chartered Council on Graduate Medical Education, the National Board of
Medical Examiners, and the Accreditation Council for Graduate Medical Education)
• Represented educational mission of VA in national forums such as the Robert Wood Johnson
Foundation National Advisory Committee
• Implemented new directions in VA health care by establishing and maintaining special
fellowships to support unique and evolving health care needs
• Monitored trends in health professional education and medical care to align VA programs with
national trends
Key Accomplishments:
• Developed mission statement and strategic plan for the Office of Academic Affiliations which
served as the template for guiding OAA’s transition from an organization focused solely on
resource allocation to one focusing on broad aspects of the educational mission
• Established VHA as a leader in health professional education through creation of
Interprofessional fellowships training individuals from diverse medical backgrounds in palliative
care and psychosocial rehabilitation. Training in palliative care contained an innovative
dissemination project to assure the education benefited the training environment as well as the
individual trainee
• Initiated realignment of VA’s Special Fellowship Programs with the health care needs of veterans
• Innovated structural redesign in the fellowship programs by creating hub sites for new programs,
which integrate curriculum and activities across program sites. These hub sites, through
enhanced web-based and video communication, have created a community of VA Special
Fellows, achieving new levels of alignment with VA goals and fostering a sense of participation
in VA
• Improved communication with field facilities through use of electronic media and customer
service orientation
• Established an external advisory committee to solicit broad input on critical issues relating to
graduate medical education (Graduate Medical Advisory Committee)

• Fostered partnership with diverse stakeholders to develop better processes for registering,
credentialing and orienting the over 70,000 trainees
• Reinvigorated VA’s academic status through improved relationships with Association of
American Medical Colleges and improved communication regarding intellectual property rights
4
 Stephanie H. Pincus, M.D., M.B.A.

• Achieved national recognition for implementation of the Learners’ Perceptions Survey as a

measurement tool for assessing the performance of the educational mission of VA
• Recognized as skilled effective leader whose policies created an excellent working environment;
OAA was recognized as the most “family friendly” workplace in the 2002 Employee Survey
• Integrated modern technology into office operations to enhance office efficiency
• Advanced change management in high impact areas such as the CARES
• Established personal relationships with field education leaders
• Created new web trainee registration process to identify all individuals receiving clinical training
in VA facilities
• Marketed VA’s health professional education mission through scholarly publications and
participation in academic activities
• Guided HIPPA implementation for trainees across the country
• Initiated comprehensive review of VA’s medical resident education portfolio, including
geographic distribution, specialty mix, and alignment with affiliated medical schools integrating
economic modeling, philosophical framework and VA needs
• Collaborated with National Board of Medical Examiners in developing pilot project to use
innovative computer technology to assess physician performance

Department of Dermatology, University at Buffalo

Professor and Chair, 1989-2000
Chief, Department of Dermatology, Kaleida Health, Buffalo, New York, 1998-2000
(Note: Kaleida Health was formed by a merger of hospitals in Buffalo, including Buffalo
General Hospital and Children’s Hospital of Buffalo)
Chief, Department of Dermatology, Children’s Hospital of Buffalo, Buffalo, New York, 1991-1998
Chief, Department of Dermatology, Buffalo General Hospital, Buffalo, New York, 1989-1998
Chief of Dermatology, Veterans Administration Hospital, Buffalo, New York, 1995-1997, 2000
Program Director, Residency Training Program in Dermatology, Graduate Medical and Dental
Consortium of Buffalo, 1989-2000
Key Responsibilities:
• Administrative responsibility for all dermatology activities at university-affiliated teaching
hospitals
• Provided academic leadership for all programmatic activities in dermatology, including research,
education, and teaching
• Managed departmental faculty clinical practice plan and represented department in university-
wide faculty practice plan activities
• Served as Program Director for the Residency Training Program in Dermatology
• Demonstrated national leadership in dermatology through participation in national and
international organizations such as the American Academy of Dermatology

5
 Stephanie H. Pincus, M.D., M.B.A.

Key Accomplishments:
• Transformed department through technology, modern clinical practice, and research
• Achieved successful accreditation of residency training program, which had been on probation
for over 10 years
• Built highly respected clinical practice with international recognition for dermatologic care of
female patients
• Developed clinical research unit, which performed multiple studies funded by the pharmaceutical
industry
• Recruited multiple diverse full-time faculty to join the academic department
• Established faculty practice plan for members of the university department
• Received national recognition for leadership in dermatology through election to the American
Dermatological Association and the Board of Directors of the American Academy of
Dermatology
• Created new programs in career development for the Women’s Dermatologic Society
• Elected President of the Women’s Dermatologic Society
• Demonstrated national leadership in medicine through election as President of the Harvard
Medical School Alumni Association
• Named in “Best Doctors in America”

Department of Dermatology, Tufts University-New England Medical Center, Boston, MA

Associate Dermatologist-in-Chief, 1986-89
Vice-Chairman, 1982-89
Dermatologist, 1982-89
Associate Professor, 1982-89
Assistant Professor, 1979-82
Department of Medicine, Tufts University-New England Medical Center, Boston, MA
Physician, 1982-89
Associate Professor, 1982-89
Assistant Professor, 1977-82
Key Responsibilities:
• Developed grant-funded, peer reviewed research program
• Assumed responsibility for all dermatology education and care pending establishment of a
Department of Dermatology; thereafter fully participated in all departmental academic activities
• Participated in graduate education in immunology
Key Accomplishments:
• Awarded 15 years continuous NIH funding for research activities in inflammation and host
defense, including Clinical Investigator Award from the National Institutes of Health
• Initiated clinical research for evaluation of new pharmaceutical agents in treatment of skin
disease
• Participated in first studies showing efficacy of new class of drugs for treatment of psoriasis
• Established internationally recognized clinical practice for evaluation and treatment for female
patients with gynecologic dermatologic conditions
• Sabbatical as Visiting Scientist at Biogen Corporation, Cambridge, MA where served as Medical
Director for New Product Identification
• Generated sufficient interest for university and hospital to reestablish Department of Dermatology

6
 Stephanie H. Pincus, M.D., M.B.A.

Dept. of Medicine, Veterans Administration Hospital, Seattle, WA

Chief, Dermatology Section, 1975-1977
Assistant Professor, Dept. of Medicine (Dermatology), University of Washington, Seattle, WA 1975-
1977
Key Responsibilities:
• Oversaw delivery of all dermatologic care at Seattle VAMC
• Developed externally funded laboratory program in dermatology research
Key Accomplishments:
• Awarded position of Research Associate in VA Career Development Program
• Established new program for internal medicine residents to learn clinical dermatology

PROFESSIONAL ORGANIZATIONS (selected)

Medical Organizations
American College of Physician Executives
Harvard Medical Alumni Association
American Academy of Dermatology
American Contact Dermatitis Society
American Dermatological Association
Women’s Dermatologic Society

Scientific Organizations
American Federation for Clinical Research
Society for Investigative Dermatology
Association for Women in Science

UNIVERSITY AND HOSPITAL SERVICE (selected)

University Service Committees

Chair, Finance and Policy Committee, Governing Board of the Faculty Practice Plan, University at
Buffalo, 1999-00
Member, Executive Committee of the Governing Board of the Faculty Practice Plan, University at
Buffalo, 1999-00
Member, Contract Negotiating Committee, UB Associates (Faculty Practice Plan), University at
Buffalo, 1999
Member, Audit Committee of the Governing Board, University at Buffalo, 1998-99
Reallocation Sub-Committee of the Program Directors, Graduate Medical-Dental Consortium, 1996
Member, Governing Board of Faculty Practice Plan, University at Buffalo, 1994-00
Chair, Internal Review Committee for Ophthalmology, University at Buffalo, 1994
Member, Offsite Committee, University at Buffalo, 1993-98
Chair, Internal Review Committee for Pathology, University at Buffalo, 1993
Microbiology Search Committee, University at Buffalo, 1991

7
 Stephanie H. Pincus, M.D., M.B.A.

Program Directors’ Committee, University at Buffalo, 1989-00

Clinical Council, University at Buffalo, 1989-00
Executive Committee, University at Buffalo 1989-00
Student Promotions Committee, Tufts University School of Medicine, 1981-83
Curriculum Committee, Tufts University School of Medicine, 1980-83
Hospital Service Committees
Medical Executive Committee, Kaleida Health (CGF Health System), 1998-00
Search Committee, Pathologist in Chief, Children’s Hospital of Buffalo, 1995
Executive Committee, Children’s Hospital of Buffalo, 1993-95 & 1997-98
Boundaries Committee, Buffalo General Hospital, 1991-98
Medical Administrative Committee, Buffalo General Hospital, 1989-98
Executive Committee, Buffalo General Hospital, 1989-98

NATIONAL AND INTERNATIONAL PROFESSIONAL SERVICE (selected)

American Academy of Dermatology

Member, Ad Hoc Task Force on Disclosure of Interest, 2003-05
Member, Ad Hoc Committee on Election Activities, 2001-03
Member, Board of Directors, 2001-05
Telecommunications Task Force, 1995-99
Research Priorities Committee, American Academy of Dermatology, 1984-87

American Contact Dermatitis Society

Membership Committee, 1995-96
Nominating Committee, 1994-95
Liaison Committee, 1993-96

American Dermatologic Association

Chair, Audit Committee, 1998

American Medical Association

Delegate to the Women Physician Leaders Summit, 1994

Association of Academic Health Centers

Council on Health Workforce and Education, 2003-04

Association of Professors of Dermatology

Chair, Program Committee, 1995
Program Committee, 1993-96

Council on Graduate Medical Education

VA Representative, 2001-04

8
 Stephanie H. Pincus, M.D., M.B.A.

Harvard Medical School

President, Harvard Medical Alumni Association, 1995-96
President-Elect, Harvard Medical Alumni Association, 1993-95
Advisory Committee - Women in Medicine, 1994
Boston Alumni Committee, 1988
Councilor, Harvard Medical School Alumni Association, 1980-82

International Society for the Study of Vulvar Disease

Editorial Board, Vulvo-Vaginal Review, 1988
Executive Council, 1985-87

National Board of Medical Examiners

VA Representative, 2001-04
Member, Nominating Committee, 2001-02

National Institute of Health

NIH Study Section for Asthma, Allergic, and Immunologic Diseases Cooperative Program, 1993

Robert Wood Johnson Clinical Scholars

National Advisory Committee (VA Liaison), 2001-04

Society of Investigative Dermatology

Chair, Joint Committee for Advancement of the Dermatological Health of Women, 1996-97
Delegate to the Consortium for Skin Research, 1996
Delegate to Joint Commission for Advancement of the Dermatologic Health of Women, 1994-98
Chair, Committee on Government and Public Relations, 1992-96

Women’s Dermatologic Society

Co-Chair, Audit Committee, 2007-present
Member, Executive Committee, 2001-02
President, 2000-01
Vice President (President Elect), 1999-00
Chair, Audit Committee, 1998-99
Member, Long Range Planning Committee, 1995-97
Director, Leadership Career Development Workshop, 1994-96
Board of Directors, 1992-96

COMMUNITY SERVICE

Board of Directors, CEPA (Center for Environmental and Perceptional Art), Buffalo, New York,
1994-96, 2009-present
Medical Advisory Committee, AIDS Community Services of Western New York, Inc., 1996-00
Quality Assurance/Risk Management Committee of Community Blue Insurance, 1990
Medical Advisory Board, Scleroderma Association, 1986-88

9
 Stephanie H. Pincus, M.D., M.B.A.

TEACHING ACTIVITIES (selected)

Academic Teaching Activities

Co-Director, Dermatology – Practice Pearls in Primary Care (a CME course for primary care
physicians), University at Buffalo, 1996-97
Introduction to Clinical Medicine, University at Buffalo, 1989-96
Director, Dermatology Section, Postgraduate Medical Institute, Boston, MA, 1987-88
Member and Lecturer, Immunology Faculty of Sackler School for Graduate Biomedical
Studies, Tufts University School of Medicine, 1985-89
Program Director, American Academy of Dermatology Annual National Meeting, 1985-89
Director, Postgraduate Course Dermatology Update for Office Practice, 1985-87
Postgraduate Review of Advances in Internal Medicine, Department of Medicine, Tufts, 1984-87
University School of Medicine
Thesis Advisor for Peggy Cammaratta, Masters Degree in Immunology, Tufts University School of
Medicine, 1984
Co-Director, Postgraduate Course Dermatology Update, Tufts University School of Medicine, 1983
Visiting Professor Program, Tufts University School of Medicine, Rumford, ME, 1982-86
Director, Second Year Course in Dermatology, Tufts University School of Medicine, 1979-85

Professional Development Activities

Faculty, Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for
Women, Drexel University College of Medicine, Philadelphia, PA, 2005-06
National Coach, Advanced Clinic Access Systems Improvement Project, Department of
Veterans Affairs, Washington, DC, 2002-03
Faculty, Association of American Medical Colleges Mid-Career Women Faculty Professional
Development Seminar, Washington, DC, 2001-03

CLINICAL RESEARCH ACTIVITIES

Director, Clinical Research Unit, Department of Dermatology, University at Buffalo, 1990-00

Principal Investigator, Study of RO-15-1570 in Photoaging, New England Medical Center, 1988-89
Co-Investigator, “Treatment of Psoriasis with 1,25-Dihydroxyvitamin D3,” New England Medical
Center, 1988-89
Director, Phototherapy Unit, Department of Dermatology, New England Medical Center, 1985-87

CORPORATE ACTIVITIES

Member, The Cosmos Council, Washington, DC, 2006-present

Consultant Medicis Pharmaceutical Corporation, 2000
Consultant/Speaker, Novartis Pharmaceutical, 1997-98
Consultant, Hoffman-La Roche Pharmaceutical, Soriatane Advisory Board, 1997-98
Consultant, Allergan Pharmaceutical, 1995-98
Consultant, Asta Pharmaceutical, 1993
Consultant, Bristol-Myers Squibb, 1989-96
Medical Director for New Product Identification, Biogen Corporation, Cambridge, MA, 1988-89
Consultant, Schering Corporation, Bloomfield, NJ, 1985

10
 Stephanie H. Pincus, M.D., M.B.A.

REVIEWER FOR REFERRED JOURNALS (selected)

Journal of Immunology
New England Journal of Medicine
Journal of Investigative Dermatology
Journal of the American Medical Association
Archives of Dermatology
Journal of the American Academy of Dermatology
Journal of Histochemistry and Cytochemistry
Journal of Immunologic Methods
Journal of Women’s Health

RECENT PRESENTATIONS

2009
American Academy of Dermatology Annual Meeting, “Pharmaceutical Compliance Update: What
Clinicians and Educators Need to Know,” invited presentation, San Francisco, CA, 3/6/09

University of Rochester School of Medicine and Dentistry, Leadership Development for Mid-Career
Faculty, “The RAISE Project: Recognizing the Achievements of Women in Sciences and
Medicine,” invited presentation, Rochester, NY, 1/26/09

2008
Tufts Symposium on Women in Science, Medicine and Engineering, “Women and Leadership,” invited
presentation, Boston, MA, 4/4/08
National Institute of Environmental Health Sciences Women’s History Month Lecture Series, “RAISE-
ing the Status of Women in Science, Medicine and Engineering,” invited presentation, Research
Triangle Park, NC, 3/10/08

2007
AAMC WIM/SELAM Plenary Session, Women’s Academic Advancement: The Influence of Language,
“The RAISE Project,” presentation and panel, New York, NY, 11/4/07

AAMC Physician Workforce Research Conference, “Women in the Physician Workforce: Maximizing
Contributions and Improving the Success of Women in Academic Medicine,” presentation and
moderator of panel, Bethesda, MD, 5/3/07

2006
AAMC Physician Workforce Research Conference, “Women in the Physician Workforce: Maximizing
Contributions and Anticipating Generational Shifts,” presentation and moderator of panel,
Washington, DC, 5/5/06
AAMC Physician Workforce Research Conference, “The Federal Role in Medical Education: VA and
DOD” presentation and plenary panel discussion, Washington, DC, 5/4/06
Office of Women’s Careers Brigham and Women’s Hospital, Harvard Medical School, “Having It All:
From All at Once to All in Time,” faculty development program, Boston, MA, 2/14/06

2005

11
 Stephanie H. Pincus, M.D., M.B.A.

American Association of University Women, “Having It All: From All at Once to All in Time,”
Alexandria VA, 12/10/05

AAMC Physician Workforce Research Conference, “Women in the Physician Workforce: Can the
United States Learn from International Experiences? Poster presentation, Washington, DC,
5/5/05
AAMC Physician Workforce Research Conference, “Women in the International Physician Workforce:
Implications for Workforce Planning,” presentation, Washington, DC, 5/5/05
AAMC Physician Workforce Research Conference, Women in The Physician Workforce: Implications
for Workforce Planning, panel moderator and organizer, Washington, DC, 5/5/05
Leonard M. Miller School of Medicine, University of Miami, “From “Glass Ceiling to Quicksand:
Planning Your Career,” presentation to students, Miami, FL, 4/27/05
Leonard M. Miller School of Medicine, University of Miami, “From “Glass Ceiling” to Quicksand:
Improving the Success of Women in Medicine,” presentation to faculty, Miami, FL, 4/26/05
Leonard M. Miller School of Medicine, University of Miami, “From “Glass Ceiling to Quicksand:
Implications for Faculty Recruitment and Retention,” presentation to Department Chairs, Miami,
FL, 4/26/05

PRESENTATIONS IN NATIONAL VA POSITION (selected)

2004
VA National Quality Scholars Summer Institute, “Quality Scholars with VA National Goals”, Lake
Fairlee, VT, 8/6/04

2003
Advanced Clinic Access and Resident Clinics, “Adapting Advanced Clinic Access to Resident Clinics”,
VA Central Office, Washington, DC, 1/9/03
Council of Teaching Hospitals and Health Systems Spring Meeting, “Moderator for Panel on Current
Issues in VA’s Educational Affairs”, Phoenix, AZ, 3/6/03

2002
Physician Residents Satisfaction in VA – An Analysis and Reflection, VA Central Office, Washington,
DC, 12/4/02
Special Medical Advisory Group, “Current Issues in VA’s Educational Activities, VA Central Office,
Washington, DC, 9/25/02
National Leadership Board, “Creating and Expanding Hospice & Palliative Care Programs in VA”,
Washington, DC (OAA & Geriatrics & Extended Care), 4/16/02
Baldrige Team Leaders Meeting, “Process Management in VA”, Washington, DC, 4/15/02
Department of Dermatology, University of Alabama, “What’s in it for me? Medical Education and the
VA”, Birmingham, AL, 3/7/02

12
 Stephanie H. Pincus, M.D., M.B.A.

2001
National Leadership Board, “Learners’ Perceptions: A Tool for Assessment of the Education Mission”,
Washington, DC, 10/16/01
Yale University Department of Dermatology, “What’s in it for me? Medical Education and the VA”,
Yale University, New Haven, CT, 10/10/01
Association of VA Chiefs of Medicine Annual Meeting, “The VA Horizon: Challenges and
Opportunities”, San Diego, CA, 8/29/01
Association of American Medical Colleges, Group on Resident Affairs, “VA Update: An Overview of
Education in VA”, Scottsdale, AZ, 5/1/01
Special Medical Advisory Group, “VA Role in Graduate Medical Education”, VA Central Office,
Washington, DC, 4/11/01
National Association of VA Dermatologists, American Academy of Dermatology, “Perspectives on VA’s
Academic Mission”, Washington, DC, 3/3/01

INVITED LECTURES AND VISITING PROFESSORSHIPS (selected)

1999
Invited Speaker, Dermatology Foundation Sixteenth Annual Winter Colloquium
Invited Speaker, Pennsylvania Academy of Dermatology

1998
Invited Speaker, Dermatologic Issues for the Primary Care Physician, New York, New York
Invited Speaker, Dermatologic Essentials for Gynecologic/Obstetric Physicians, Dept. of Gynecology
and Obstetrics, University at Buffalo
Invited Speaker, Psoriasis: A Therapeutic Update, Pittsburgh Dermatology Society
Visiting Professor, Department of Dermatology, University at Brooklyn

1997
Invited Speaker, Dermatology for the Non-Dermatologist, CMEA/San Diego State University
Invited Speaker, Vulvar Disease, City Wide Grand Rounds, Dept of Gynecology and Obstetrics, State
University of New York at Buffalo

1996
Director, Genital Disease Forum, American Academy of Dermatology
Invited Speaker, What’s New in Dermatology?, American Academy of Dermatology
Invited Speaker, Dermatology for the Internist, Medical Ground Rounds, University at Buffalo
Invited Speaker, Dermatology for Ophthalmologists, Ophthalmology Grand Rounds,
University at Buffalo

1995
Herman Gardner Memorial Lecturer, Baylor College of Medicine, 12th Biennial Conference on
Diseases of the Vulva and Vagina
Director, Genital Disease Forum, American Academy of Dermatology
Invited Speaker, Harvard Medical Alumni Association

13
 Stephanie H. Pincus, M.D., M.B.A.

1994
Eduard G. Friedrich Memorial Lecturer, University of Florida
Invited Speaker, Israel Society for the Study of Vulvovaginal Diseases, International Conference on
Lower Female Genital Tract Diseases, Israel
Visiting Professor, Brown University School of Medicine, Providence, Rhode Island
Director, Genital Disease Forum, American Academy of Dermatology

1993
Director, Dermatology for the Office, A Course for Primary Care Physicians, University at Buffalo

1992
Dermatology Update, American Academy of Dermatology, New York City, “Mentioning the
Unmentionable”
Visiting Professor, Department of Dermatology, Oregon Health Sciences University

1991
Participant, Genital Disease Forum, American Academy of Dermatology
Invited Speaker, Chicago Dermatology Society
New England Dermatologic Society Clinical Day

1990
Participant, Genital Disease Forum, American Academy of Dermatology
Visiting Professor, Department of Dermatology, University of Missouri School of Medicine
Visiting Professor, Department of Dermatology, State University of New York Health Sciences
Center at Brooklyn

1989
Director, “Do Drugs Work? And How!” Symposium, American Academy of Dermatology
Visiting Professor, Department of Dermatology, New York University

1988
Director, “Do Drugs Work? And How!” Symposium, American Academy of Dermatology
Visiting Lecturer, Elizabeth Garrett Anderson Hospital, London, England

1987
Director, “Do Drugs Work? And How!” Symposium, American Academy of Dermatology
Genital Diseases in the Elderly and Vulvar Diseases in the Elderly, Westwood Carolina Conference
on Clinical Dermatology, Hilton Head, NC
Memorial Day Program, Department of Obstetrics and Gynecology, Queen’s University, Kingston,
Ontario

1980-1986
Department of Dermatology, Yale University School of Medicine
Department of Dermatology, Emory University, Atlanta, GA
Department of Dermatology, Columbia University, New York, NY
Department of Dermatology, Baystate Medical Center, Springfield, MA
Lupus Education Day sponsored by the National Inst. Of Health
Director, “Do Drugs Work? And How!” Symposium, American Academy of Dermatology (1985-
1989)
New England Dermatology Society
14
 Stephanie H. Pincus, M.D., M.B.A.

Meet the Professor, American College of Physicians Annual Meeting, (1985-1988)

Director, “Problems in Vulvar Disease,” Focus Session, American Academy of Dermatology, (1985-
1987)
Visiting Professor Program, Tufts University School of Medicine (Rumford Community Hospital,
Rumford, ME, Choate Hospital, Woburn, MA)
Vulvar Intraepithelial Neoplasia” Massachusetts General Hospital, Boston, MA
“Diseases of the External Female Genitalia” Department of Dermatology, New York University
Medical Center (Advances in Dermatology Course) (1985)
“Functional Studies of Eosinophils” University Hospital, Department of Clinical Chemistry, Uppsala,
Sweden (1985)
“Functional Studies of Eosinophils” University of Lund, Lund, Sweden
Recent Advances in Internal Medicine, Tufts University School of Medicine (1984-1988)
“Eosinophils in Immunological Reactions” Sixth International Congress on Immunology, Toronto,
Canada (1982)

GRANT SUPPORT

“Partnerships for Adaptation, Implementation and Dissemination (PAID): Advancing Ways of Awarding
Recognition in Discipline-Related Professional Societies (AWARDS)”, Co-Principal Investigators: Betsy
Kean, Anne Lincoln, Janet Bandows Koster, Stephanie H. Pincus,, Association for Women in Science
and Society for Women’s Health Research, National Science Foundation, 9/1/2009-8/31/2012 Award -
$796,834

“National Awards Clearinghouse to Improve Recognition of the Achievements of Women in Science,

Medicine, and Engineering,” Principal Investigator: Stephanie Pincus, M.D., Society for Research in
Women’s Health, Alfred P. Sloan Foundation, 10/05-9/07, Award - $45,000

“Implementation/Evaluation Evidence-based Coordinators in Residency Training,” Co-Investigator:

Stephanie Pincus, M.D., Principal Investigator: T. Michael Kashner, VA HSR&D/VISN Implementation
Collaborative Planning Grant, 1/04-6/04, Award - $50,000

“Eosinophils in Cancer,” Principal Investigator: Stephanie Pincus, M.D., Troup Foundation Grant, 7/95-
6/96, Award - $22,500

“Eosinophils in Cancer,” Principal Investigator: Stephanie Pincus, M.D., Troup Foundation Grant, 7/94-
6/95, Award - $22,500

“Eosinophils in Cancer,” Principal Investigator: Stephanie Pincus, M.D., Troup Foundation Grant, 7/93-
6/94, Award - $22,000

“Eosinophils in Cancer,” Principal Investigator: Stephanie Pincus, M.D., Troup Foundation Grant, 7/92-
6/93, Award - $21,000

“Eosinophils in Neoplastic Disease,” Principal Investigator: Stephanie Pincus, M.D., Troup Foundation
Grant, 7/91-6/92, Award - $18,000

“Eosinophil-Mediated Fibrosis,” Principal Investigator: Stephanie Pincus, M.D., Scleroderma

Foundation, 7/90-6/91, Award $33,300

15
 Stephanie H. Pincus, M.D., M.B.A.

Allergic Disease Center Grant: Project 1, “Lymphocyte-Eosinophil Interactions,” Principal Investigator,

Stephanie H. Pincus, M.D., National Institutes of Health, 9/88-8/93, Award - $313,000

“Cellular Interactions: Lymphocytes and Eosinophils,” Principal Investigator: Stephanie H. Pincus,

M.D., National Institutes of Health, 7/82-8/88, Award - $962,000

“The Eosinophil Peroxidase System,” Principal Investigator: Stephanie H. Pincus, M.D., National
Institutes of Health, 12/79-5/88, Award - $900,609

“Drug Effects on Leukocyte Function,” Principal Investigator: Stephanie H. Pincus, M.D., Upjohn
Company, 9/79-8/80, Award - $6,000

CLINICAL RESEARCH STUDIES

“A Clinical Study Evaluating the Safety and Efficacy of Azelaic Acid 20% Cream Used in Combination
with M.D. Forte Facial Lotions Compared with Tretinoin 0.025% Cream Used in Combination with a
Vehicle in the Treatment of Individuals with Acne Vulgaris,” Allergan Pharmaceutical, 1/97-1/98, Award
- $29,243

“Dovonex (Calcipotriene Ointment) 0.005% in the Treatment of Actinic Keratoses,” Bristol-Myers

Squibb, 6/96-10/96, Award - $20,982

“A Comparison of Azelaic Acid 20% Cream Compared with the Vehicle in the Treatment of Individuals
with Melasma or Other Forms of Facial Hyperpigmentation,” Allergan Pharmaceutical, 2/96-2/97, Award
- $38,805

“Investigator-Masked Study of the Safety and Efficacy of Tazarotene (AGN 190168) 0.1% Gel Plus
Corticosteroid Cream or Placebo Cream each Applied Once-Daily for 12 Weeks in the Treatment of
Plaque Psoriasis,” Allergen Pharmaceutical, 2/96-1/97, Award - $23,700

“An Open-Label Multicenter Trial to Evaluate the Safety and Effectiveness of Various Treatment
Durations of Terbinafine in Patients with Onychomycosis of the Toenails,” Sandoz, 8/95-12/96, Award -
$9,000

“An Initial Phase II, Double-Blind, Parallel-Group, Dose-Ranging Study of BMS-181162 1% and 5%
Solutions versus their Vehicle in the Treatment of Atopic Dermatitis,” Bristol-Myers Squibb, 3/95-6/95,
Award - $27,214

“An Initial Phase II, Double-Blind, Parallel-Group, Dose-Ranging Study of BMS-181162, 1% and 5%
Solutions versus their Vehicle in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb, 3/95-9/95,
Award - $29,520

“A Randomized, Double-Blind Matched-Pair Comparison of Kamillosan Cream vs. Placebo Cream in the
Prevention of Radiation Dermatitis of the Ear Pinnae and Subauricular Fold in Patients Receiving
Bilateral Irradiation of the Head,” Asta Medica, Inc., 6/94-10/94, Award - $39,791

“A Double-Blind, Parallel Study of the Efficacy and Safety of Calcipotriene Cream 0.005% versus its
Vehicle in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb, 2/94-7/94, Award - $28,000

16
 Stephanie H. Pincus, M.D., M.B.A.

“An Open Label, Compassionate Use Study Monitoring the Long Term Safety and Efficacy of Topical
Naloxone Lotion, 0.5% in Subjects with Pruritic Mycosis Fungoides or Sezary Syndrome,” GenDerm
Corp., 6/93-6/95

“A Double-Blind, Randomized, Vehicle-Controlled Crossover Study Evaluating the Safety and Efficacy
of Topical Naloxone Lotion, 0.5%, in Subjects with Pruritic Mycosis Fungoides or Sezary Syndrome,”
GenDerm Corp, 06/93-10/94, Award - $33,125

“A Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Efficacy and Safety of Lac-Hydrin

12% Cream versus Vehicle in Subjects with Ichthyosis Vulgaris” Bristol-Myers Squibb, 6/93-12/93,
Award - $23,625

“An Open, Phase I Tolerance and Efficacy Study of Cytarabine in the One Week Treatment of
Condyloma Acuminatum,” Chemex Pharmaceuticals, Inc., 4/93-9/93, Award - $24,993

“A Randomized, Double-Blind, Parallel Group Comparison of the Efficacy and Safety of Calcipotriene
0.005% Ointment versus Fluocinonide 0.05% Ointment (Lidex) in the Treatment of Plaque Psoriasis,”
Bristol-Myers Squibb Co., 4/93-6/93, Award - $16,625

A Double-Blind Parallel Group Comparison of the Efficacy, Safety and Compatibility of Calcipotriene
Ointment 0.005% Along, and in Combination with Halog Ointment 0.1%, Westcort Ointment 0.2% and
Hytone Ointment 2.5% in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb Co., 9/92-1/93,
Award - $23,488

“A Randomized Evaluator-Blind, Within-Subject Comparison of the Microanatomical Effects of Lac-

Hydrin 12% Lotion, its Vehicle and no Treatment in Subjects with Ichthyosis Vulgaris, “ Bristol-Myers
Squibb Co., 1/92-7/92, Award - $32,574

“A Double Blind Parallel Group Study Utilizing Hematology, Urinalysis Blood and Urine Chemistry and
Bone Densitometry to Evaluate the Safety and Efficacy of 0.005% MC 903 ointment verses its Vehicle in
the Treatment of Psoriasis, Bristol-Myers Squibb Co., 8/91-3/92, Award - $88,189

“A Multi-Center, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral 256U87 for the
Treatment of Herpes Zoster in Immunocompetent Patients Less Than 50 Years Old,” Burroughs
Wellcome Co., 3/91-9/92, Award - $121,000

“A Multi-Center, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral 256U87 for the
Treatment of Herpes Zoster in Immunocompetent Patients 50 Years of Age & Older,” 3/91-9/92

“A Double-Blind, Parallel Study of the Efficacy and Safety of Calcipotriol Ointment 0.0005% versus its
Vehicle in the Treatment of Plaque Psoriasis, “ Bristol-Myers Squibb Co., 1/91-6/91, Award - $27,150

“The Biology of Eosinophils”, Principal Investigator: Stephanie H. Pincus, M.D., National Institute of
Health, 12/78-11/81, Award - $114,400 (Clinical Investigator Award)

17
 Stephanie H. Pincus, M.D., M.B.A.

PUBLICATIONS

Lincoln A, Pincus S, and Schick V. Evaluating Science or Evaluating Gender? The Back Page, APS
News 18(6):8, 2009.

Chang BK, Murawsky J, Feldman J, Holland G, Kashner T, Pincus S, and Sanders K. Resident
Physicians in VA Outpatient Clinics: Continuity and Advanced Clinic Access Implementation. Fed Pract
24(5):35-54, 2007.

Singh D, Holland G, Melander E, Mickey D, and Pincus S. VA’s Role in U.S. Health Professions
Workforce Planning. Papers and Proceedings of the 13th Federal Forecasters Conference of 2003 127-
133, 2004.

Keitz S, Holland G, Melander E, Bosworth H, and Pincus S for the Learners’ Perceptions Working
Group. The Veterans Affairs Learners’ Perceptions Survey: The Foundation for Educational Quality
Improvement. Acad Med 78(9):910-917, 2003.

Pincus S, Wolff E, and Melander E. The VA National Quality Scholars Fellowship Program: Current
Status, Future Directions. Qual Manag Health Care 10(3):71-76, 2002.

Christiano AM, Crollick J, Pincus S, and Uitto J. Squamous cell carcinoma in a family with dominant
dystrophic epidermolysis bullosa: a molecular genetic. Exp Dermatol 8(2):146-152, 1999.

Lowe NJ, Rizk D, Grimes P, Billips M, and Pincus S. Azelaic acid 20% cream in the treatment of facial
hyperpigmentation in darker-skinned patients. Clin Ther 20(5):945-959, 1998.

Spellman MC and Pincus SH. Efficacy and safety of azelaic acid and glycolic acid combination therapy
compared to tretinoin therapy for acne. Clin Ther 20(4):7ll-721, 1998.

Mashek H, Licznerski B, and Pincus S. Tungiasis in New York. Int J Dermatol 36:276-301, 1997.

Guzzo C, Lazarus G, Goffe B, Pincus S. et al. Topical calcipotriene has short term no effect on calcium
and bone metabolism of patients with psoriasis. J Am Acad Dermatol 34:429-433, 1996.

Zellis S and Pincus S. Treatment of vulvar dermatoses. Semin Dermatol 15(1):71-76, 1996.

Foon K, Vaickus L, Oseroff AR, Russell RN, Bernstein Z, Pincus S. et al. Immune responses in patients
with cutaneous T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-
cell antigen. Clin Cancer Res 1:1285-1294, 1995.

Kircik L, Armus S, Kipping H, and Pincus SH. Eccrine poroma in an unusual location. Cutis 54:183-
184, 1994.

Pincus S. Women in Academic Dermatology: Results of survey from the professors of dermatology.
Arch Dermatol 130:1131-1135, 1994.

Birkland T, Cheavens M, and Pincus S. Human eosinophils stimulate DNA synthesis and matrix
production in dermal fibroblasts. Arch Dermatol Res 286:312-318, 1994.

Zellis S and Pincus SH. When the pregnant woman experiences itching. Dermatol Nurs 5:380-383,
1993.

18
 Stephanie H. Pincus, M.D., M.B.A.

Amster M, Conway J, Zeid M, and Pincus S. Cutaneous necrosis secondary to protein S deficiency and
increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad
Dermatol 29(5 pt 2):853-857, 1993.

Wieselthier J, Pincus S. Hailey-Hailey disease of the vulva: A report of 3 cases and review of the
literature. Arch Dermatol 129(10):1344-1345, 1993.

Conway B, Baskar P, Bechtel LJ, Kaplan JC, Hirsch MS, Schooley RT, Pincus SH. Eosinophils as host
cells for HIV-1. Arch Virol 127(1-4):373-377, 1992.

Romero L, Pincus SH. Interleukin 6 in normal skin and atrophic cutaneous disease. Inter Arch Allergy
Immunol 99(1):44-49, 1992

Kircik LH, Wirth P, Pincus SH. Scars on the legs: Cutaneous fibrosis resulting from intracutaneous
injection of cocaine. Arch Dermatol 128(12):6143-0, 1992.

Baskar P and Pincus SH. Eosinophil degranulation: Selective regulation of enzyme release by IL-1 beta.
Proc Soc Exp Biol Med 199(2):249-54, 1992.

Baskar P, Silberstein D, and Pincus SH. Inhibition of IgG triggered eosinophil function by IL-4. J
Immunol 144:2321-2326, 1990.

Romero L, Ikejima T, and Pincus SH. In situ localization of interleukin 1 in normal and psoriatic skin. J
Invest Dermatol 93:518-522, 1989.

Whitcomb EA, Dinarello CA, and Pincus SH. Modulation of eosinophil function by tumor necrosis
factor. Int Arch Allergy Appl Immunol 89:250-255, 1989.

Whitcomb EA, Dinarello CA, and Pincus SH. Effects of IL-1 alpha and IL-1 beta on different
subpopulations of human peripheral blood eosinophils. Blood 73:1904-1908, 1989.

Konnikov N, Dinarello CA, and Pincus SH. Elevated plasma interleukin-1 levels in humans following
ultraviolet light therapy for psoriasis. J Invest Dermatol 92:235-239, 1989.

Baskar P and Pincus SH. Eosinophil degranulation: Enhancement in the presence of oxygen. Infect
Immunol 56:1907-1911, 1988.

Smith EL, Pincus SH, Donovan L, and Holick MF. A novel approach for the evaluation and treatment of
psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for
psoriasis. J Am Acad Dermatol 19:516-528, 1988.

Holick MF, Smith E, and Pincus SH. Skin as the site of vitamin D synthesis and target tissue for 1,25-
dihydroxyvitamin D3. Arch Dermatol 123:1677-1683a, 1987.

Ramesh KS, Rocklin R, and Pincus SH. Phosphorylation and dephosphorylation of soluble proteins in
human eosinophils. J Cell Biochem 34:203-211, 1987.

Pincus SH, Ramesh KS, and Wyler DJ. Eosinophils stimulate fibroblast DNA synthesis. Blood 70:572-
574, 1987.

Kaplan MM, Arora S, and Pincus SH. Primary sclerosing cholangitis. Clinical and histological response
to low-dose methotrexate therapy. Ann Intern Med 106:231235, 1987.

19
 Stephanie H. Pincus, M.D., M.B.A.

Ramesh KS, Rocklin R, and Pincus SH. Activated eosinophils synthesize new proteins. Biochem
Biophys Acta 923:241-249, 1987.

Pincus SH, Whitcomb E, and Dinarello CA. Interaction of IL-l and TPA in modulation of eosinophil
function. J Immunol 137:3509-3514, 1986.

Pincus SH, Cammarata PC, Delima M, and Despommier D. Eosinophilia in murine trichinellosis. J
Parasitol 72:321-325, 1986.

Pincus SH. Lectin binding by eosinophils. Proc Soc Exp Biol Med 182:344-349, 1986.

Pincus SH, and Cammarata PC. Eosinophil adherence to muscle larvae of Trichinella spiralis:
Quantification and modulation. Immunology 56:219-225, 1985.

Ramesh KS, Pincus SH, and Rocklin R. Human lymphocyte-eosinophil interactions. I. Modulation of
phytohemagglutinin-induced lymphocyte proliferation by eosinophils. Cell Immunol 92:366-375, 1985.

Bjornson BB, Pincus SH, DiNapoli AM, and Desforges JA. Inhibition of CFU-NM and CFU-EOS by
mature granulocytes. Blood 63:376-379, 1984.

Pincus, SH. Eosinophil-particle interactions. A model system for study of cellular adherence and
activation. Cell Immunol 86:460-471, 1984.

Jacoby W, Cammarata PC, Findlay S, and Pincus SH. Anaphylaxis in mast cell deficient mice. J Invest
Dermatol 83:302-304, 1984.

Pincus SH, Dessein A, Lenzi H, and David JR. Eosinophil-mediated killing of schistosomula of
Schistosoma mansoni: Oxidative requirement for enhancement by eosinophil colony stimulating factor
(CSF-alpha) and supernatants with cytotoxicity enhancing activity (E-CEA). Cell Immunol 87:424-433,
1984.

Vadas MA, Varigos G, Nicola N, Pincus SH, Dessein A, Metcalf D, and Battye FL. Eosinophil
activation by colony stimulating factor in man: Analysis by flow cytometry. Blood 61:1232-1242, 1983.

Pincus SH. Hydrogen peroxide release from eosinophils: Quantitative comparative studies of human and
guinea pig eosinophils. J Invest Dermatol 80:278-281, 1983.

Pincus SH, DiNapoli AM, and Schooley WR. Superoxide production by eosinophils. Modulation by
histamine. J Invest Dermatol 79:53-57, 1982.

Kelly RA, Gelfand JA, and Pincus SH. Cutaneous necrosis caused by systemically administered heparin.
JAMA 246:1502-1503, 1981.

Pincus SH, DiNapoli AM, Schooley WR, and Broder S. Metabolic heterogeneity among eosinophils
from normal and hypereosinophilic patients. Blood 58:1175-1181, 1981.

Pincus SH, Butterworth A, David JR, Robbins M, and Vadas M. Antibody-dependent eosinophil-
mediated damage to schistosomula of Schistosoma mansoni: Lack of requirement for oxidative
metabolism. J Immunol 126:1794-1798, 1981.

Wolf R, Pincus SH, Rosen F, and Merler E. Diffuse cutaneous lymphoma secreting a potent
immunosuppressant. Clin Immunol Immunopathol 18:351-361, 1981.

20
 Stephanie H. Pincus, M.D., M.B.A.

Pincus SH. Peroxidase mediated iodination by guinea pig peritoneal exudate eosinophils. Inflammation
4:89-106, 1980.

Pincus SH. Comparative metabolism of guinea pig eosinophils and neutrophils. Proc Soc Exp Biol Med
163: 482-489, 1980

Pincus SH. Production of eosinophil-rich guinea pig peritoneal exudates. Blood 52:127-134, 1978.

Pincus, SH, Boxer LA, and Stossel TP. Chronic neutropenia in childhood: Analysis of 16 cases and a
review of the literature. Am J Med 61:849-861, 1976.

Pincus SH, Thomas IT, Clark RA, and Ochs HD. Defective neutrophil chemotaxis with variant
ichthyosis hyperimmunoglobulinemia E and recurrent infections. J Ped 87:908-911, 1975.

Giblett ER, Klebanoff SJ, Pincus SH, Swanson J, Park BH, and McCullough J. Kell phenotypes in
chronic granulomatous disease: A potential transfusion hazard. Lancet 1:1235, 1971.

Klebanoff SJ and Pincus SH. Hydrogen peroxide utilization in myeloperoxidase deficient leukocytes: A
possible control mechanism. J Clin Invest 50:2226-2229, 1971.

Pincus SH and Klebanoff SJ. Quantitative leukocyte iodination. N Engl J Med 284:744-750, 1971.

ABSTRACTS

Lincoln AE, Pincus S, and Schick V. Predicting Women’s Receipt of Physics Awards. Panel
presentation at the Southern Sociological Society, April 2009.

Schick VR, Lincoln A, and Pincus S. The RAISE Project: Gender Disparities in Science, Technology,
Engineering, Mathematics and Medicine (STEMM) Awards. Association for Women in Psychology 34th
Annual Conference, March 2009.

Pincus SH, Schick V, and Haseltine F. The RAISE Project. Poster Presentation at National Leadership
Workshop on Mentoring Women in Biomedical Careers, November 2007.

Pincus SH and Haseltine F. Improving Recognition and Enhancing Rewards. AAMC Physician
Workforce Research Conference, May 2007.

Pincus SH. Gender and Generations: Anticipating Changes in Physician Expectations. AAMC Physician
Workforce Research Conference, May 2006.

Kashner TM, Chang BK, Holland GJ, Hinson RS, Melander E, Mickey D, Kashner T, Sanders KM, and
Pincus SH. Do Residents Contribute to Clinical Care? AAMC Physician Workforce Research
Conference, May 2005.

Pincus SH. Women in the Physician Workforce: Implications for Workforce Planning Women in the
International Physician Workforce. AAMC Physician Workforce Research Conference, May 2005.

Pincus SH. Women in the Physician Workforce: Can the United States Learn from International
Experiences? AAMC Physician Workforce Research Conference, May 2005.

21
 Stephanie H. Pincus, M.D., M.B.A.

Chang BK, Kashner TM, Holland GJ, Mickey D, Berkowitz A, Hinson R, Melander E, Pincus SH, and
Sanders KM. Methods to Study the Geographic Distribution of Physician Residents in the VA System.
Poster Presentation. AAMC Physician Workforce Research Conference, May 2005.

Buchanan R, Holland G, Melander E, Mickey D, and Pincus S. Learners’ Perceptions of Dental Trainees
in VA and non-VA Institutions. Exhibit Presentation. American Dental Education Association Annual
Meeting, 2002.

Holland G, Aron D, Cannon G, Gilman S, Graber M, Kaminetzky C, Keitz S, Melander E, Mickey D, and
Pincus S. National Physician Resident Learners’ Perceptions Survey. IME Section of the AAMC Annual
Meeting, 2002.

Keitz S, Holland G, Aron D, Cannon G, and Pincus S. Learners’ Perceptions of Physician Resident
Training Experience in Veterans Affairs (VA) Medical Centers. Scientific Poster Presentation.
Association of American Medical Colleges (AAMC) Annual Meeting, 2002.

Pincus S, Holland G, Keitz S, Aron D, and Cannon G. Learners’ Perceptions of Clinical Training
Experience in Veterans Affairs Medical Centers. Scientific Poster Presentation for Innovations in
Medical Education Section (IME). Society of General Internal Medicine Annual Meeting, 2002.

Lowe NJ, Grimes P, Pincus S, and Harper H. Efficacy and safety of azelaic acid 20% cream in the
treatment of facial hyperpigmentation in darker skinned patients. Am Acad of Dermatol Annual Meeting,
1998.

Spellman MC, Piacquadio DJ, and Pincus S. Azelaic acid and glycolic acid combination for mild to
moderate acne. Am Acad of Dermatol Annual Meeting, 1998.

Pincus S, Oseroff A, Breneman D, Foss F. Koh H, Duvic M. Vonderheid EC, Coe B, Phillips SB, and
Bernstein JE. Effectiveness of topical Naloxone HCL, 0.05%, in the treatment of pruritus associated with
mycosis fungoides (MF) and Sezary syndrome (SS). J Invest Dermatol 104:661, 1995.

Birkland TP, Solecki D, Oseroff AR, and Pincus SH. Cytokine modulation of eosinophil-mediated
cytotoxicity. Clin Res 41:609A, 1993.

Oseroff AR, Chatterjee M, Russell D, Vaikus L, Pincus SH, Stoll H, Beers TF, Kohler H, and Foon KA.
Monoclonal anti-idiotype vaccine therapy for cutaneous T cell lymphoma. J Invest Dermatol 101:414A,
1993.

Birkland T, Solecki D, Oseroff A, and Pincus S. Tumor cell cytotoxicity is mediated by human
eosinophils (EOS). Clin Res 41(2):468A, 1993.

Wehr R, Gibson J, Epinette W, Chesnut C, Goffe B, Katz I, Fridley MN, Lazarus G, Lowe N, and Pincus
S. The safety of topically applied calcipotriene ointment 0.005% (a vitamin D2 analogue) as measured by
blood, urine and bone density analysis in psoriatic patients. Skin Pharmacol Soc Proc, 1993.

Birkland T, Oseroff A, and Pincus S. Human eosinophils (EOS) are cytotoxic to a carcinoma cell line.
Clin Res 4(3):669A, 1992.

Birkland T, Cheavens M, and Pincus SH. Human eosinophils stimulate fibroblast growth. Clin Res
40(2):465A, 1992.

Goldman B, Fujihara K, Bisaccia E, Pincus S, Greenberg SJ, and Oseroff AR. HTLV retroviral
homologous sequences in mycosis fungoides/Sezary syndrome. J Invest Dermatol 98:660A, 1992.

22
 Stephanie H. Pincus, M.D., M.B.A.

Birkland T, Cheavens M, and Pincus SH. Human eosinophils stimulate fibroblast growth. Clin Res
39(3):675A, 1991.

Romero L and Pincus SH. Interleukin-6 is increased in atrophic cutaneous disease. Clin Res 37(2):694A,
1989.

Konnikov N, Ree HJ, Dinarello CA, and Pincus SH. Interleukin-1 (IL-1) is present in psoriatic plaques.
Clin Res 35(3):696A, 1987.

Holick, MF, Smith EL, and Pincus SH. A new approach for the treatment of psoriasis: Topical or oral
use of 1,25-dihydroxyvitamin D3 may be a safe and effective therapy for psoriasis. Clin Res 35(3):581A,
1987.

Konnikov N, Dinarello CA, and Pincus SH. Ultraviolet B (UVB) therapy increases human plasma
interleukin-1 (IL-1) levels. Lymphokine Res 6:1209, 1987.

Pincus SH, Whitcomb EA, and Dinarello CA. Interaction of interleukin-1 (IL-1) and PMA in modulation
of eosinophil function: Implications for IL-1 mechanism of action. Lymphokine Res 6:1208, 1987.

Pincus SH, Whitcomb EA, and Dinarello CA. Interleukin-1 (IL-1) increases lymphocyte intracellular
Ca++. Clin Res 39:503A, 1986.

Konnikov N, Dinarello CA, and Pincus SH. UVB therapy increases interleukin-1 (IL-1) in vivo. Clin
Res 39:760A, 1986.

Ramesh KS, Pincus SH, and Rocklin R. Characterization of a lymphocyte inhibitory factor derived from
activated eosinophils. Clin Res 33:386A, 1985.

Pincus SH, Whitcomb E, Rocklin R, and Dinarello CA. Interleukin 1 enhances eosinophil function. Clin
Res 33:385A, 1985.

Pincus SH, Cammarata PC, Kurtzberg L, Delima M, and Despommier D. Eosinophilia in murine
trichinosis. 6th Int Conf on Trichinellosis, McGill Univ., 1985.

Pincus SH and Mier JM. Modulation of eosinophil helminthotoxicity by lymphocyte-derived factors.

Clin Res 32:380A, 1984.

Rocklin R, Kiselis I, and Pincus SH. Modulation of PHA-induced lymphocyte proliferation by human
eosinophils (eos). Clin Res 31:540A, 1983.

Pincus SH, DiNapoli AM, and Rocklin R. Oxidative metabolism of eosinophils: Modulation by
lymphokine(s). Clin Res 31:350A, 1983.

Jacoby W, Pincus SH, Cammarata PC, and Findlay S. Mast cell deficient mice develop immediate
hypersensitivity. Clin Res 30:580A, 1982.

Pincus SH, Vadas M. Dessein A, DiNapoli AM, and David JR. Eosinophil helminthotoxicity:
Enhancement via an oxidative mechanism. Clin Res 30:376A, 1982.

Wyler DJ and Pincus SH. Eosinophils contain fibroblast stimulating factor. Clin Res 29:379A, 1981.

23
 Stephanie H. Pincus, M.D., M.B.A.

Pincus SH, Alroy J, and Fallon J. A guinea pig model for hypereosinophilic syndrome. Clin Res
29:171A, 1981.

Pincus SH, Schooley WR, and DiNapoli AM. Eosinophil function modulated by histamine. Clin Res
29:172A, 1981.

Pincus SH, DiNapoli AM, Schooley WR, and Broder S. Functional heterogeneity among eosinophils.
Clin Res 28:321A, 1980.

Pincus SH, Butterworth A, Vadas M, Robbins M, and David JR. Eosinophil specific non-oxidative
killing of schistosomula. Clin Res 28:376A, 1980.

Pincus SH. Eosinophil iodination: Regulation by cyclic nucleotides. Clin Res 27:244A, 1979.

Pincus SH. Active eosinophil iodination. Clin Res 26:300A, 1978.

Pincus SH. Comparative metabolism of eosinophils and neutrophils. Clin Res 25:345A, 1977.

Pincus SH and Smith P. A new model for experimental eosinophil production. Clin Res 25:100A, 1977.

Pincus SH and Stossel TP. Macrophage plasma membrane: Association with contractile proteins. Clin
Res 24:109A, 1976.

Stossel TP and Pincus SH. A new macrophage actin-binding protein: Evidence for its role in
endocytosis. Clin Res 23:407A, 1975.

Pincus SH and Klebanoff SJ. Quantitative leukocyte iodination. Clin Res 19:185A, 1971.

BOOK CHAPTERS

Pincus S and Zellis S. Miscellaneous Agents-Vitamin D (calcipotriol). In McDonald C (ed):

Immunomodulatory and Cytoxic Agents in Dermatology. Marcel Dekker, Inc., 157-167, 1996.

Pincus SH and Shah F. Classification and Treatment of Inflammatory Diseases of Pregnancy. In Dahl
MV and Lynch PJ (eds): In Current Opinion in Dermatology, Second Edition, Current Science, 1995.

Shanler SD, Zellis SL, Oseroff AR, and Pincus SH. Application of the Polymerase Chain Reaction to the
Diagnoses of Infectious Diseases of the Skin. In Erlich GD and Greenberg SJ (eds): PCR-Based Clinical
Diagnostics. Blackwell Scientific Publications, Inc., 1994.

Holbrook KA, Pincus S, Parker F, Holloway Jr. GA, Kraning KB, Yancey K, and Lawley TJ. Structure,
Function, and Immunology of the Skin. In Middleton Jr. E, Reed CE, Ellis EF, Adkinson Jr. NF,
Yunginger JW, and Busse WW (eds): ALLERGY: Principles and Practice, Fourth Ed, Vol 1, Mosby
Year Book, Inc., 1993.

Pincus SH and McKay M. Disorders of the Anogenitalia of Females. In Fitzpatrick TB, Eisen AZ, Wolff
K, Freedberg I , and Austen KF (eds): Dermatology in General Medicine. Fourth Ed. 113(1):1463-1481,
McGraw Hill, 1993.

Pincus SH. Vulvar Dermatoses and Pruritus Vulvae in Dermatologic Clinics. Turner MLC and Marinoff
(eds): W. B. Saunders Company, 10(2):297-308, 1992.
24
 Stephanie H. Pincus, M.D., M.B.A.

Pincus SH. Non-Venereal Diseases of the Female Genitalia. In Moschella SL and Hurley HJ (eds):
Dermatologic Medicine and Surgery. W.B. Saunders Company, 1991.

Rocklin R and Pincus SH. Atopic Dermatitis. In Austen KF, Samter M, Talmage D, Claman H, and
Frank M (eds): Immunological Diseases. Fourth Ed. Little, Brown & Co., 1988.

Pincus SH and Stadecker MJ. Vulvar Dystrophies and Non-Infectious Inflammatory Conditions. In
Wilkinson EJ (ed): Pathology of the vulva and vagina. New York: Churchill Livingstone Inc, 1987.

Pincus SH. Diseases of the Female Genitalia. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, and
Austen KF (eds): Dermatology in General Medicine. Third Ed. McGraw Hill, 1986.

Pincus SH. Cutaneous Eosinophilic Diseases. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, and
Austen KF (eds): Dermatology in General Medicine. Third Ed. McGraw Hill, 1986.

Pincus SH. The Eosinophil. In Stone JF (ed): Dermatologic Allergy and Immunology. C.V. Mosby Co.,
1985.

Pincus SH. Contact Dermatitis. In Kagan B and Gellis S (eds): Current Pediatric Therapy. W.B.
Saunders Co., 1984.

Pincus SH and Wolff SM. Eosinophilic Diseases of the Skin. In Austen KF and Fitzpatrick TB (eds):
Update I: Dermatology in General Medicine, McGraw Hill, 1983.

Pincus SH. Dermatologic Care of the Surgical Patient. In Molitch M (ed): Management of Medical
Problems in Surgical patients. 3rd Ed. F.A. David Pub. Co., Philadelphia, 1982.

Pincus SH. Dermatology. In Proger S and Barza M (eds): Diagnostic Imperatives. Thieme Stratton,
Inc., New York, 1981.

October 2009

25